SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-17-000369
Filing Date
2017-11-20
Accepted
2017-11-20 15:33:01
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pcsa_10q.htm 10-Q 227466
2 CERTIFICATION pcsa_ex311.htm EX-31.1 6185
3 CERTIFICATION pcsa_ex312.htm EX-31.2 6205
4 CERTIFICATION pcsa_ex321.htm EX-32.1 2470
5 CERTIFICATION pcsa_ex322.htm EX-32.2 2439
  Complete submission text file 0001393905-17-000369.txt   1692153

Data Files

Seq Description Document Type Size
6 pcsa-20170930.xml EX-101.INS 250172
7 pcsa-20170930.xsd EX-101.SCH 25682
8 pcsa-20170930_cal.xml EX-101.CAL 23902
9 pcsa-20170930_def.xml EX-101.DEF 42302
10 pcsa-20170930_lab.xml EX-101.LAB 154596
11 pcsa-20170930_pre.xml EX-101.PRE 138741
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 171213656
SIC: 2834 Pharmaceutical Preparations